{
  "asset": "TAR-210 (RIS/erdafitinib)",
  "query_terms": [
    "TAR-210 (RIS/erdafitinib)",
    "RIS/erdafitinib",
    "TAR-210 (RIS",
    "erdafitinib)"
  ],
  "returned_unique": 1,
  "kept": 1,
  "studies": [
    {
      "nct_id": "NCT03390504",
      "title": "A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "phase": "Phase 3",
      "conditions": [
        "Urothelial Cancer"
      ],
      "lead_sponsor": "Janssen Research & Development, LLC",
      "collaborators": [],
      "interventions": [
        "Erdafitinib",
        "Vinflunine",
        "Docetaxel",
        "Pembrolizumab",
        "Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA)"
      ],
      "last_update": "2025-12-22",
      "ctgov_url": "https://clinicaltrials.gov/study/NCT03390504"
    }
  ]
}